Zobrazeno 1 - 10 of 38 pro vyhledávání: '"Nagisa Oshima-Hasegawa"'
1
Akademický článek
Detection of clonal plasma cells in POEMS syndrome using multiparameter flow cytometry
Autor: Arata Ishii, Shokichi Tsukamoto, Naoya Mimura, Yurie Miyamoto-Nagai, Yusuke Isshiki, Shinichiro Matsui, Sanshiro Nakao, Asuka Shibamiya, Yutaro Hino, Kensuke Kayamori, Nagisa Oshima-Hasegawa, Tomoya Muto, Yusuke Takeda, Tomoki Suichi, Sonoko Misawa, Chikako Ohwada, Koutaro Yokote, Satoshi Kuwabara, Chiaki Nakaseko, Hiroyuki Takamatsu, Emiko Sakaida
Publikováno v: Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein [M-protein], and skin changes) is a rare systemic disorder characterized by various symptoms caused by underlying plasma cell (PC) dyscrasia. Detection of monoc
Externí odkaz: https://doaj.org/article/9b8f610b006b45589b8f86626a22aab6
Zobrazit plný text záznamu
2
Akademický článek
The combination of the tubulin binding small molecule PTC596 and proteasome inhibitors suppresses the growth of myeloma cells
Autor: Yurie Nagai, Naoya Mimura, Ola Rizq, Yusuke Isshiki, Motohiko Oshima, Mohamed Rizk, Atsunori Saraya, Shuhei Koide, Yaeko Nakajima-Takagi, Makiko Miyota, Tetsuhiro Chiba, Nagisa Oshima-Hasegawa, Tomoya Muto, Shokichi Tsukamoto, Shio Mitsukawa, Yusuke Takeda, Chikako Ohwada, Masahiro Takeuchi, Tohru Iseki, Chiaki Nakaseko, William Lennox, Josephine Sheedy, Marla Weetall, Koutaro Yokote, Atsushi Iwama, Emiko Sakaida
Publikováno v: Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Abstract The novel small molecule PTC596 inhibits microtubule polymerization and its clinical development has been initiated for some solid cancers. We herein investigated the preclinical efficacy of PTC596 alone and in combination with proteasome in
Externí odkaz: https://doaj.org/article/481913bfae7549a8909dc48c57cf66bb
Zobrazit plný text záznamu
3
Akademický článek
Successful allogeneic bone marrow transplantation after massive gastrointestinal bleeding in a patient with myelodysplastic syndrome associated with intestinal Behçet-like disease
Autor: Arata Ishii, Shokichi Tsukamoto, Tatsuzo Mishina, Shintaro Izumi, Yurie Nagai, Miki Yamazaki, Yutaro Hino, Kensuke Kayamori, Nagisa Oshima-Hasegawa, Tomoya Muto, Shio Mitsukawa, Yusuke Takeda, Naoya Mimura, Chikako Ohwada, Chiaki Nakaseko, Jun-ichiro Ikeda, Emiko Sakaida
Publikováno v: Leukemia Research Reports, Vol 16, Iss , Pp 100278- (2021)
A 45-year-old woman was diagnosed with myelodysplastic syndrome (MDS) with trisomy 8 and Behçet-like disease (BLD) with multiple colorectal ulcers. Nonspecific inflammatory cells were infiltrated in the intestinal mucosa, whereas fluorescence in sit
Externí odkaz: https://doaj.org/article/393c811684ac4cb4948e5a4ed89d09a4
Zobrazit plný text záznamu
7
Myeloid/Lymphoid Neoplasm with PDGFRB Rearrangement with t (5;10) (q33;q22) Harboring a Novel Breakpoint of the CCDC6-PDGFRB Fusion Gene
Autor: Yasuhiro Ishizuka, Shokichi Tsukamoto, Emiko Sakaida, Motoharu Fukazawa, Shio Mitsukawa, Chiaki Nakaseko, Nagisa Oshima-Hasegawa, Masahiro Takeuchi, Tomoya Muto, Miki Yamazaki, Shinichi Ozawa, Yusuke Takeda, Naoya Mimura, Yasuhito Hatanaka, Chikako Ohwada, Tohru Iseki
Publikováno v: Internal Medicine. 58:3449-3453
Myeloid/lymphoid neoplasms with PDGFRB rearrangement are a distinct type of myeloid neoplasms that occur in association with rearrangement of PDGFRB at 5q32. The hematological features most often show prominent eosinophilia. We herein report a patien
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::86683388c9a2c671c5222b0381a0ecf8
https://doi.org/10.2169/internalmedicine.3220-19
Zobrazit plný text záznamu
9
Low incidence of thromboembolism in multiple myeloma patients receiving immunomodulatory drugs; a retrospective single-institution analysis
Autor: Koji Takaishi, Yusuke Takeda, Tohru Iseki, Kensuke Kayamori, Shokichi Tsukamoto, Tatsuzo Mishina, Chikako Ohwada, Shio Mitsukawa, Yusuke Isshiki, Naoya Mimura, Yohei Kawasaki, Emiko Sakaida, Miki Yamazaki, Kenji Kimura, Masahiro Takeuchi, Yutaro Hino, Nagisa Oshima-Hasegawa, Yurie Nagai, Chiaki Nakaseko
Publikováno v: Journal of Thrombosis and Thrombolysis. 48:141-148
Anti-platelet agents or anticoagulants are administered for patients with multiple myeloma (MM) receiving immunomodulatory drugs (IMiDs) to prevent thrombotic events (TEs). However, there is a discrepancy between current guidelines and clinical pract
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f814c7e6410c953bc94e8efb3e668cef
https://doi.org/10.1007/s11239-019-01809-w
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje